Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the ODISSEA Study.

Sponsor
Azienda Sanitaria-Universitaria Integrata di Udine (Other)
Overall Status
Recruiting
CT.gov ID
NCT04860687
Collaborator
(none)
309
8
5
38.6
7.7

Study Details

Study Description

Brief Summary

Acute respiratory insufficiency is one of the principal causes of intensive care admission for COVID 19 positive patients. This may determine a variable mortality rate ranging from 25-30%.

In these patients, many days of non-invasive or invasive mechanical ventilation are needed to correct severe hypoxemia.

Mechanical ventilation is not a direct therapy but allows the clinicians to prolong the "time-to-recovery" interval necessary for COVID 19 respiratory insufficiency treatment.

Long intensive care stay, mechanical ventilation, the use of steroids and sedatives have an impact on the survivors.

Previous studies demonstrated that patients admitted to intensive care with non-COVID acute respiratory distress syndrome had a reduction in the quality of life even up to one year after discharge.

The aim of this study is to understand if COVID-19 related acute respiratory distress syndrome has a worse impact on the quality of life one year after discharge when compared with non-COVID-19 acute respiratory distress syndrome.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    309 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the ODISSEA Study.
    Actual Study Start Date :
    Aug 1, 2021
    Anticipated Primary Completion Date :
    Nov 30, 2021
    Anticipated Study Completion Date :
    Dec 31, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Short Form Health Survey 36 [One year after discharge]

      Evaluate the physical abilities of patients discharged from the intensive care unit after admission for COVID-19 respiratory insufficiency. The scale ranges from 0 to 100, where 0 is the worse value and 100 is the best.

    Secondary Outcome Measures

    1. Impact of Event Scale - Revised (IES-R) [One year after discharge]

      Identify post traumatic stress disorder in patients discharged from the intensive care unit after admission for COVID-19 respiratory insufficiency. The scale ranges from 0 to 88, where 0 is the best value and 88 the worst.

    2. Age [One year after discharge]

      Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the age of the patients

    3. Gender [One year after discharge]

      Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the gender of the patients

    4. Scholarship [One year after discharge]

      Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the scholarship of the patients

    5. Marital status [One year after discharge]

      Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the marital status of the patients

    6. Steroids [One year after discharge]

      Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the use of steroids

    7. Muscle relaxants [One year after discharge]

      Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the use of muscle relaxants

    8. Renal replacement therapy [One year after discharge]

      Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with the use of renal replacement therapy

    9. Tracheostomy [One year after discharge]

      Evaluate if there is an association between quality of life measured with Short Form Health Survey 36 scale and Impact of Event Scale - Revised and post traumatic stress disorder with tracheostomy

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 99 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients discharged from the intensive care unit after admission for COVID-19 respiratory insufficiency that requested non-invasive or invasive mechanical ventilation
    Exclusion Criteria:
    • history of dementia

    • history of behavior disorders

    • pre-existing tracheostomy

    • advanced oncologic disease

    • end-stage-organ disease (dialysis, or enlisted for organ transplantation)

    • no consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Anesthesia and Intensive Care, Academic Hospital of Catanzaro Catanzaro Calabria Italy
    2 Anesthesia, Intensive Care and Pain Therapy, Academic Hospital "Federico II" of Naples Naples Campania Italy
    3 Anesthesia and Intensive Care, Academic Hospital of Ferrara Ferrara Emilia Romagna Italy
    4 Anesthesia and Intensive Care 2, Academic Hospital of Parma Parma Emilia Romagna Italy
    5 Anesthesia and Intensive Care Department, Ravenna Hospital Ravenna Emilia Romagna Italy
    6 Department of Anesthesia and Intensive Care, Academic Hospital of Udine Udine Friuli Venezia Giulia Italy 33100
    7 Anesthesia and Intensive Care 1, Hospital of Trento Trento Trentino Alto Adige Italy
    8 Anesthesia and Intensive Care 2, Perugia Hospital Perugia Umbria Italy

    Sponsors and Collaborators

    • Azienda Sanitaria-Universitaria Integrata di Udine

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Luigi Vetrugno, Clinical Professor in Anesthesiology and Intensive Care, Azienda Sanitaria-Universitaria Integrata di Udine
    ClinicalTrials.gov Identifier:
    NCT04860687
    Other Study ID Numbers:
    • ODISSEA 1.0
    First Posted:
    Apr 27, 2021
    Last Update Posted:
    Oct 7, 2021
    Last Verified:
    Sep 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 7, 2021